MENU
+Compare
NBTX
Stock ticker: NASDAQ
AS OF
Oct 17 closing price
Price
$25.60
Change
-$0.97 (-3.65%)
Capitalization
1.33B

NBTX Nanobiotix SA Forecast, Technical & Fundamental Analysis

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy... Show more

NBTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for NBTX with price predictions
Oct 17, 2025

NBTX saw its Stochastic Oscillator recovers from the overbought zone

The Stochastic Oscillator for NBTX moved out of overbought territory on October 17, 2025. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 49 similar instances where the indicator exited the overbought zone. In of the 49 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for NBTX moved out of overbought territory on October 14, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 22 similar instances where the indicator moved out of overbought territory. In of the 22 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NBTX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

NBTX broke above its upper Bollinger Band on October 08, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for NBTX just turned positive on September 17, 2025. Looking at past instances where NBTX's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

Following a +4 3-day Advance, the price is estimated to grow further. Considering data from situations where NBTX advanced for three days, in of 196 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 122 cases where NBTX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NBTX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (24.226). P/E Ratio (0.000) is within average values for comparable stocks, (54.529). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.181). Dividend Yield (0.000) settles around the average of (0.036) among similar stocks. P/S Ratio (144.928) is also within normal values, averaging (349.660).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NBTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
NBTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
60 Rue de Wattignies
Phone
+33 140260470
Employees
102
Web
https://www.nanobiotix.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SCIJX22.100.05
+0.23%
Hartford Schroders International Stk SDR
ECDIX18.870.04
+0.21%
Eaton Vance Global Equity Income C
WRHIX5.970.01
+0.17%
Macquarie High Income Fund Class C
RLUEX12.94-0.01
-0.08%
Lazard US Equity Concentrated R6
MICYX10.28-0.01
-0.10%
Victory Trivalent Intl Fd-Core Eq Y

NBTX and Stocks

Correlation & Price change

A.I.dvisor tells us that NBTX and PBYI have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NBTX and PBYI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NBTX
1D Price
Change %
NBTX100%
-3.65%
PBYI - NBTX
28%
Poorly correlated
+1.11%
GLMD - NBTX
26%
Poorly correlated
-2.84%
EWTX - NBTX
26%
Poorly correlated
-1.70%
CRMD - NBTX
25%
Poorly correlated
+0.99%
VALN - NBTX
25%
Poorly correlated
-1.86%
More